MedPath

A clinical trial to study the effects of drugs i.e. intravenous nalbuphine and dexmedetomidine as premedication on emergence agitation in adult patients undergoing abdominal surgery.

Not yet recruiting
Conditions
Delirium due to known physiological condition,
Registration Number
CTRI/2020/11/029347
Lead Sponsor
GGS Medical College and Hospital Faridkot Punjab
Brief Summary

Emergence agitation (EA) is one of the most common complications after general anaesthesia. EA comprises of agitation, confusion,disorientation or violent behaviour in the early phase of recovery from generalanaesthesia. Nalbuphine and dexmedetomidine are the two drugs we are going to compare on the basis of incidence, severity, hemodynamic variability and side effects. This study will be having two groups with sample size of 40 in each group including both males and females of age between 18 to 55 years and excluding patients with history of anaphylaxis or allergy to the study drugs and patients refusing for consent etc.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients of age between 18 to 55 years, undergoing abdominal surgery under General anaesthesia (GA).

Exclusion Criteria
  • 1.Duration of surgery ≤ 1 hour.
  • 2.Patient having renal, hepatic, cardiovascular and cerebral dysfunction.
  • 3.History of anaphylaxis or allergy to the study drugs 4.BM I >30 kg/m2.
  • 5.Psychiatric disorders or drug abuse.
  • •Patients refused to participate in study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the effect of IV nalbuphine and dexmedetomidine on incidence of EA.Hourly monitoring till 12 hours.
Secondary Outcome Measures
NameTimeMethod
1.Severity of EA.2.NRS score for Post Operative Pain (POP) assessment.

Trial Locations

Locations (1)

GGS Medical College and Hospital, Faridkot, Punjab

🇮🇳

Faridkot, PUNJAB, India

GGS Medical College and Hospital, Faridkot, Punjab
🇮🇳Faridkot, PUNJAB, India
Gurwinder Kaur
Principal investigator
9464311295
gkmalhi95@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.